跳至主要内容
临床试验/NCT05141890
NCT05141890进行中(未招募)不适用

Probiotics for Inflammation in Pediatric Chronic Pain

Medical College of Wisconsin1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2022年4月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
39
试验地点
1
主要终点
Change in systemic inflammation - CRP

研究概览

简要总结

To examine benefits of a probiotic for youth with chronic pain and a Body Mass Index >=85th percentile.

详细描述

The purpose of the current study: (1) examine whether a 7-11 week supplement of a single-strain probiotic (Lactobascillus Plantarum, Lp299v) reduces systemic inflammation; (2) determine whether reductions in systemic inflammation will correlate with reductions in pain, disability, mood impairment and changes in mechanical pain threshold and mechanical pain sensitization; (3) Explore whether reductions in systemic inflammation will correlate with reductions in other outcomes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
13 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Male or female biological sex
  • 13-17 years of age
  • Body Mass Index ≥85th percentile for sex and age

排除标准

  • Probiotic (or prebiotic) supplement use or antibiotic use within the past month
  • Chronic inflammatory or autoimmune disease with the exception of well-controlled hypothyroidism or intermittent or mild persistent asthma not requiring the use of daily inhaled steroids
  • Patients who have had a poor response to blood draw or immunizations in the past
  • Chronic use of medications known to alter gastrointestinal function or inflammation (e.g. metformin, non-steroidal anti-inflammatory medications)
  • Any condition that, in the investigator's opinion, may compromise study participation or may confound the interpretation of the study results
  • Use of illicit drugs
  • Females who are pregnant or lactating

研究组 & 干预措施

Probiotic

Experimental

Participants will be given the probiotic supplement Lp299v. The supplement is taken by mouth in the form of capsules. Participants will undergo a screening visit. After 7-11 weeks of taking Lp299v, they will return for their final visit. Blood will be drawn before and after the 7- 11 week intervention.

干预措施: Lactobacillus Plantarum (Dietary Supplement)

结局指标

主要结局

Change in systemic inflammation - CRP

时间窗: 7-11 weeks

Change in circulating C-Reactive Protein after 8 weeks of probiotic supplement.

次要结局

  • Change in Worst Pain intensity(7-11 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Keri Hainsworth

Associate Professor

Medical College of Wisconsin

研究点 (1)

Loading locations...

相似试验